Extending the Validation of SCREEN to Persons Living With Dementia or in Retirement Homes
Launched by UNIVERSITY OF WATERLOO · Dec 14, 2020
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
About a third of cognitively well, community-living older Canadians are at nutrition risk, which has been shown to lead to hospitalizations, poor quality of life, and death. Since SCREEN was created 20 years ago, there has been considerable growth in the number of community-living older adults diagnosed with mild cognitive impairment or dementia (i.e., MCI-D) and/or living in retirement homes. These two groups are nutritionally vulnerable. Nutrition risk is specifically associated with the progression of cognitive impairment and frailty, as well as caregiver burden. Yet, these groups are un...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 55 years of age or older
- • potential participants with MCI-D will have a caregiver who either lives with the participant or is in daily contact OR
- • potential participants have subjective complaint - MoCA used to confirm cogntive change OR
- • Retirement home participants will have lived in their residence for a minimum of 3 months
- • read and communicate in English
- • provide written consent or assent for persons MCI-D; caregiver written consent required if participant with cognitive change unable to provide
- Exclusion Criteria:
- • living in a nursing home
- • do not speak or read English
- • live outside of the geographic boundaries of this study (i.e., \> 45 km from Kitchener/Waterloo or London).
About University Of Waterloo
The University of Waterloo is a leading research institution located in Ontario, Canada, known for its innovative approach to education and commitment to advancing knowledge across various disciplines. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to translate research findings into practical applications for health and wellness. Leveraging cutting-edge technology and a robust network of academic and industry partnerships, the University of Waterloo is dedicated to improving patient outcomes and fostering advancements in healthcare through rigorous scientific inquiry and ethical clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guelph, Ontario, Canada
Patients applied
Trial Officials
Heather Keller
Principal Investigator
U Waterloo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials